Green Lifescience Co., Ltd. (KOSDAQ:114450)

Market Cap	45.59B -21.1%
Revenue (ttm)	51.02B +120.0%
Net Income	3.01B
EPS	155.32
Shares Out	19.53M
PE Ratio	15.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	216,575
Open	2,275.00
Previous Close	2,260.00
Day's Range	2,275.00 - 2,405.00
52-Week Range	1,673.00 - 4,590.00
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Green Lifescience

Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbony...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2005
• Employees: 70
• Stock Exchange: KOSDAQ
• Ticker Symbol: 114450

Financial Performance

In 2025, Green Lifescience's revenue was 40.34 billion, an increase of 62.26% compared to the previous year's 24.86 billion. Earnings were 110.13 million, a decrease of -92.95%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 18, 2026

Data Sources Report a data error